Contact(s) :
Hélène PRIMERANO
helene.primerano [at] univ-lorraine.fr
Document(s) à télécharger :
Conference poster171.41 KB
-
Videoconference
Dans le cadre de la journée scientifique de l'Ecole Doctorale Biose, le Pr Odile LAUNAY donnera une conférence, le 02 juin 2021 en visioconférence, intitulée : "Messenger RNA vaccines".
Summary:
Only 18 months after the WHO declaration of the COVID-19 pandemic, 13 vaccines are currently in use worldwide and 22 in phase 3 development. Among these vaccines, those using mRNA are the most promising. Using a technology that has been in development for about 20 years, they have rapidly established themselves as effective, safe and adaptable to viral variants. In addition to their short-term interest in the current health crisis, they represent a major innovation in medicine.
Only 18 months after the WHO declaration of the COVID-19 pandemic, 13 vaccines are currently in use worldwide and 22 in phase 3 development. Among these vaccines, those using mRNA are the most promising. Using a technology that has been in development for about 20 years, they have rapidly established themselves as effective, safe and adaptable to viral variants. In addition to their short-term interest in the current health crisis, they represent a major innovation in medicine.